Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostatic Neoplasms, Locally Advanced”

149 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 149 results

Testing effectiveness (Phase 2)Looking for participantsNCT04585750
What this trial is testing

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Who this might be right for
Advanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more
PMV Pharmaceuticals, Inc 300
Early research (Phase 1)Study completedNCT00403221
What this trial is testing

Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Baylor College of Medicine 19
Testing effectiveness (Phase 2)Looking for participantsNCT07189871
What this trial is testing

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more
Radiopharm Theranostics, Ltd 61
Not applicableUnknownNCT04220398
What this trial is testing

Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer

Who this might be right for
Prostate CancerChemotherapy EffectHormone Sensitive Prostate Cancer+1 more
RenJi Hospital 475
Testing effectiveness (Phase 2)Study completedNCT00038181
What this trial is testing

Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 18
Early research (Phase 1)Looking for participantsNCT06999187
What this trial is testing

DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Who this might be right for
Triple Negative Breast CancerHER2-negative Breast CancerNon Small Cell Lung Cancer+9 more
Dren Bio 96
Testing effectiveness (Phase 2)Ended earlyNCT04171700
What this trial is testing

Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes

Who this might be right for
Solid Tumor
pharmaand GmbH 83
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Large-scale testing (Phase 3)Looking for participantsNCT06952803
What this trial is testing

Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Who this might be right for
Prostate Cancer
AstraZeneca 700
Testing effectiveness (Phase 2)Ended earlyNCT04424641
What this trial is testing

A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumor(s)Prostate CancerEsophageal Cancer+5 more
Genmab 48
Not applicableLooking for participantsNCT04894188
What this trial is testing

Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
National Taiwan University Hospital 38
Testing effectiveness (Phase 2)Study completedNCT00027794
What this trial is testing

Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 40
Large-scale testing (Phase 3)Study completedNCT01122121
What this trial is testing

Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Locally Advanced
Takeda 273
Large-scale testing (Phase 3)Active Not RecruitingNCT03767244
What this trial is testing

Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 2,517
Testing effectiveness (Phase 2)Looking for participantsNCT07073794
What this trial is testing

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocally Advanced Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Mayo Clinic 38
Testing effectiveness (Phase 2)UnknownNCT01685190
What this trial is testing

Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Institute of Cancer Research, United Kingdom 124
Testing effectiveness (Phase 2)Active Not RecruitingNCT05722288
What this trial is testing

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Who this might be right for
Localized Prostate CarcinomaLocally Advanced Cervical CarcinomaLocally Advanced Rectal Carcinoma+15 more
City of Hope Medical Center 49
Early research (Phase 1)Study completedNCT00635596
What this trial is testing

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Who this might be right for
Solid Tumors
Amgen Research (Munich) GmbH 65
Testing effectiveness (Phase 2)UnknownNCT06227156
What this trial is testing

Disitamab Vedotin in the Treatment With HER2- Expression, Subjects With Locally Advanced or Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration-resistant Prostate Cancer
RemeGen Co., Ltd. 40
Large-scale testing (Phase 3)Ended earlyNCT00294437
What this trial is testing

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Who this might be right for
Prostate Cancer
Central European Cooperative Oncology Group 376
Next Page